1 Min Read
Nov 8 (Reuters) - Ignyta Inc
* Ignyta announces new data highlighting immune modulation of RXDX-106 at the society for immunotherapy of cancer (sitc) meeting Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.